Business
New Birmingham INVO Center Offers Families an Affordable Advanced Fertility Treatment Solution to Help Combat Rising Costs
SARASOTA, Fla., March 10, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), developers of the INVOcell®, an advanced fertility treatment technology
About this update from Invo Fertility, Inc.
[{"type":"text","content":"SARASOTA, Fla., March 10, 2022 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), developers of the INVOcell®, an advanced fertility treatment technology which is currently available through a number of channels, including its new joint-venture owned INVO Center in Birmingham, Alabama, highlights an initiative to continuously provide transparent and affordable advanced fertility treatment solutions to combat rising patient costs.\n\n \n \n \n \n \n \n\n \nClick here to watch a recent video posted by Dr. Karen Hammond: https://www.facebook.com/watch/live/?ref=watch_permalink&v=373099854816032.\n\"In today's inflationary market environment, we believe it is more important than ever to drive home the benefits of the affordable and effective INVOcell advanced fertility treatment solution,\" commented INVO CEO, Steve Shum. \"Our center in Birmingham is actively treating patients at a lower cost than often seen with conventional IVF solutions, helping the many patients that remain underserved not only in Alabama, but from the 30 states around the country from where our patients have traveled to Birmingham to seek this more affordable option. This further demonstrates our key initiative to remain focused on the democratization of fertility through the use of our revolutionary INVOcell solution.\"\nCurrently, at the Birmingham INVO Center, the all-in cost of an IVC (intravaginal culture) procedure is generally less than $7,000. Conventional IVF typically ranges from $12,000 to $15,000 per cycle.\nDr. Karen R. Hammond, DNP, CRNP, and reproductive specialist at Innovative Fertility Specialists, an INVO Center in Birmingham, commented, \"Our data have shown that IVC has a comparable pregnancy rate to conventional IVF with significantly lower costs and risks for patients. We have streamlined the entire IVC process by utilizing the INVOcell solution to make it easy for patients across the United States to receive treatment here in Birmingham. With the financial costs continuing to increase across the county, we have developed a much less-expensive option that improves access to care to all patients, including those who simply cannot afford conventional IVF.\"\nDr. Hammond and the Birmingham team have created a simple and effective roadmap to treat patients locally, and from around the country. The process begins with an initial telephone ...